Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if Abilify will reduce tics (repetitive, uncontrollable movements or vocalizations) in children and adolescents ages 7-18 with Tourette's Disorder (TD) or a chronic motor tic disorder (either repetitive, uncontrollable movements or vocalizations).


Clinical Trial Description

The aims of this study are to obtain systematic data regarding dosing and safety of aripiprazole (Abilify) in the treatment of youth with Tourette's Disorder (TD). Tourette's Disorder is characterized by multiple motor (more than one uncontrollable movement) and vocal tics (vocal outbursts) which have been present for more than 1 year, with onset before the age of 18. The disorder causes marked distress in social, occupational or other important areas of functioning. Abilify has been approved by the United States Food and Drug Administration (FDA) to treat adults with schizophrenia but has not been approved to treat Tourette's Disorder (TD) so it is considered experimental or investigational in this study. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00241176
Study type Interventional
Source New York University School of Medicine
Contact
Status Completed
Phase Phase 4
Start date September 2005
Completion date February 2010

See also
  Status Clinical Trial Phase
Recruiting NCT05370391 - Comprehensive Behavioral Intervention for Tics N/A
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Recruiting NCT03844919 - TICS: Transcranial Magnetic Stimulation for Intervening in Children With Tourette's Syndrome (CIHR) N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT03483493 - Online Remote Behavioural Intervention for Tics (ORBIT) N/A
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Withdrawn NCT04765085 - Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics N/A
Completed NCT02676492 - A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders N/A
Recruiting NCT01860300 - Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00056420 - Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement N/A
Completed NCT04128397 - An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder N/A
Recruiting NCT05547854 - Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program N/A
Completed NCT05047705 - Investigating Distress Tolerance in Adults With Tourette Syndrome N/A
Completed NCT03564132 - Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder Phase 2
Completed NCT03239210 - Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Phase 4